{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["1(2)"],"submitter":["Pozzi C"],"pubmed_abstract":["Background and aims
The SARS-CoV-2 pandemic has overwhelmed the treatment capacity of the health care systems during the highest viral diffusion rate. Patients reaching the emergency department had to be either hospitalized (inpatients) or discharged (outpatients). Still, the decision was taken based on the individual assessment of the actual clinical condition, without specific biomarkers to predict future improvement or deterioration, and discharged patients often returned to the hospital for aggravation of their condition. Here, we have developed a new combined approach of omics to identify factors that could distinguish coronavirus disease 19 (COVID-19) inpatients from outpatients.Methods
Saliva and blood samples were collected over the course of two observational cohor"],"journal":["Gastro hep advances"],"pagination":["194-209"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8818445"],"repository":["biostudies-literature"],"pubmed_title":["A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019."],"pmcid":["PMC8818445"],"pubmed_authors":["Pozzi C","Maurizio C","Ubaldi L","Braga D","Rita GA","Sonia V","Michela C","Paola B","Domenico S","Salvatore B","Penna G","Cristina B","Nicolo C","Alice S","Oresta B","Arianna C","de Nalda Ana L","Ilaria S","Rescigno M","Sara F","Ilaria M","Fabio P","Sara C","Paolo T","Alice B","Monica R","Garlanda C","Desai A","Maria FF","Federica P","Rachele DD","Elisabeth D","Claudia C","Valentina F","Darwich A","Angelotti G","Barbara D","Alessandra S","Peano C","Erica P","Azzolini E","Aldo U","Levi R","Francesca C","Valentina C","Dioguardi CC","Silvia C","Gianmarco S","Sara B","Abbass D","Politi LS","Chiara P","Silvia G","Assunta C","Alessio A","Carli F","Spadoni I","Bottazzi B","Anna P","Elisa Z","Bianca O","Antonio V","Barbieri R","Alessia M","Salvatore S","ICH COVID-19 Task-force","Carlo S","Marina S","Antonio GG","Veronica Z","Michele C","Antonino LC","Voza A","Michela L","Valeria R","Alessandro M","Mantovani A","Clement A","Giulia F","Cecconi M"],"additional_accession":[]},"is_claimable":false,"name":"A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019.","description":"Background and aims
The SARS-CoV-2 pandemic has overwhelmed the treatment capacity of the health care systems during the highest viral diffusion rate. Patients reaching the emergency department had to be either hospitalized (inpatients) or discharged (outpatients). Still, the decision was taken based on the individual assessment of the actual clinical condition, without specific biomarkers to predict future improvement or deterioration, and discharged patients often returned to the hospital for aggravation of their condition. Here, we have developed a new combined approach of omics to identify factors that could distinguish coronavirus disease 19 (COVID-19) inpatients from outpatients.Methods
Saliva and blood samples were collected over the course of two observational cohor","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2026-05-31T08:53:02.782Z","creation":"2026-04-08T08:19:33.311Z"},"accession":"S-EPMC8818445","cross_references":{"pubmed":["35174369"],"doi":["10.1016/j.gastha.2021.12.006"]}}